Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibitor for Metabolic and Viral Research

Executive Summary: Tin Mesoporphyrin IX (chloride) is a high-affinity, competitive inhibitor of heme oxygenase (HO) with a Ki of 14 nM, validated in both in vitro and in vivo models (APExBIO C5606). It effectively suppresses HO-mediated heme catabolism, reducing bilirubin production and modulating heme-dependent pathways. In animal studies, doses as low as 1 pmol/kg inhibit hepatic, renal, and splenic HO activity for extended periods. The compound is widely used to elucidate the roles of HO-1 in metabolic disease, insulin resistance, and viral infection models. Tin Mesoporphyrin IX (chloride) is available from APExBIO and is characterized by strong stability and standardized solubility parameters for research workflows.

Biological Rationale

Heme oxygenases (HO) catalyze the oxidative cleavage of heme to biliverdin, ferrous iron, and carbon monoxide. The inducible isoform, HO-1, is upregulated under oxidative stress and plays a central role in cellular redox balance, metabolic adaptation, and immune modulation (Koyaweda et al., 2026). Disruptions in HO-1 signaling have been implicated in metabolic diseases, insulin resistance, and viral pathogenesis. Pharmacological inhibition of HO activity enables precise dissection of these pathways in vivo and in vitro. Tin Mesoporphyrin IX (chloride) serves as a gold-standard probe in this context due to its specificity, potency, and pharmacokinetic profile.

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) acts as a potent, competitive inhibitor of the HO enzyme system, directly competing with native heme for binding at the HO active site. Its Ki of 14 nM demonstrates high-affinity inhibition, blocking the conversion of heme to biliverdin, thereby reducing downstream production of bilirubin and carbon monoxide. This inhibition is effective in both isolated enzyme assays and whole-animal models. The compound does not affect upstream heme synthesis or unrelated metabolic enzymes at standard research concentrations (APExBIO C5606).

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) inhibits purified rat liver HO activity with a Ki of 14 nM at 37°C, pH 7.4 (APExBIO C5606 Product Data, link).
• Single administration (1 pmol/kg, intraperitoneal) in rats suppresses hepatic, renal, and splenic HO activity for >24 hours (APExBIO C5606).
• Reduces serum bilirubin concentrations in neonatal hyperbilirubinemia animal models, confirming suppression of heme catabolism (APExBIO C5606).
• Upregulation of HO-1 modulates hepatitis B virus replication and morphogenesis, highlighting the importance of HO-1 inhibition in antiviral research (Koyaweda et al., 2026).
• Increased heme saturation of hepatic tryptophan pyrrolase after Tin Mesoporphyrin IX administration demonstrates pathway specificity (APExBIO C5606).

For a broader discussion of translational and mechanistic perspectives, see this thought-leadership article, which expands on these findings by integrating HO-1 signaling in viral pathogenesis and precision medicine. This article provides primary source validation and experimental benchmarks, extending the theoretical scope of previous reviews.

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is a reference tool in:

• Heme oxygenase activity assays in cell and tissue extracts.
• Animal models of hyperbilirubinemia and heme metabolism disorders.
• Pathway dissection in metabolic syndrome and insulin resistance research.
• Study of HO-1 signaling in viral infections, including hepatitis B virus (Koyaweda et al., 2026).
• Metaflammation and immune-metabolic interface studies.

For strategic guidance on leveraging HO inhibition in translational research, this related article offers a nuanced perspective, while this article focuses on validated experimental protocols and quantitative benchmarks.

Common Pitfalls or Misconceptions

• Tin Mesoporphyrin IX (chloride) is not a cure or therapy for hyperbilirubinemia or metabolic disease; it is a research tool only.
• It does not inhibit heme synthesis pathways or other non-HO enzymes at validated concentrations.
• Clinical trials in humans have not been reported; all efficacy claims relate to preclinical models only.
• It should not be confused with other metalloporphyrins (e.g., zinc or cobalt analogs), which differ in potency and specificity.
• Solubility and stability are limited; solutions in DMSO or DMF are recommended for short-term use only and should be stored at -20°C.

Workflow Integration & Parameters

Tin Mesoporphyrin IX (chloride) is supplied as a crystalline solid (MW 754.3, formula C₃₄H₃₄Cl₂N₄O₄Sn·2H) by APExBIO (SKU: C5606). Solubility parameters are 0.5 mg/ml in DMSO and 1 mg/ml in DMF; aqueous solubility is negligible. For optimal results, dissolve in DMSO, aliquot, and store at -20°C. Use freshly prepared solutions within 1–2 weeks. Standard experimental concentrations range from 10 nM to 10 μM, depending on assay type. For animal work, doses as low as 1 pmol/kg have sustained effects on HO activity. Always verify integrity by HPLC or UV-Vis spectroscopy before use. For detailed protocols, refer to the product page. The C5606 kit is compatible with standard heme oxygenase activity assays and metabolic pathway studies.

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride) is a cornerstone inhibitor for dissecting heme oxygenase function in metabolic and virology research. With rigorous in vitro and in vivo validation, it supports reproducible pathway analysis and translational discovery. Future studies may clarify its impact on complex disease networks and enable the development of more selective HO modulators. For further mechanistic insights and translational perspectives, see the interlinked articles above, which this review updates with benchmarked claims and workflow guidance.